Crown Assets Capital LLC – Trademark Portfolio
Entity Type: 16
Crown Assets Capital LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include EYE AM BEAUTY. The owner is based in Cheyenne, WY.
1718 Capitol Ave.
Cheyenne, WY 82001
Showing of trademarks Trademarks
Trademark Classifications
Crown Assets Capital LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Crown Assets Capital LLC have?
Crown Assets Capital LLC has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does Crown Assets Capital LLC file in?
Crown Assets Capital LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Crown Assets Capital LLC's most well-known trademarks?
Crown Assets Capital LLC's registered trademark portfolio includes well-known marks such as EYE AM BEAUTY. These are among 1 currently registered trademark in the portfolio.
What is Crown Assets Capital LLC's trademark registration success rate?
Crown Assets Capital LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.